George Medicines, a UK biopharma focused on cardiometabolic diseases, has entered into an exclusive licensing and supply ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...

Sweden’s OncoZenge has chosen Meribel Pharma Solutions—formerly Recipharm—to be the contract development and manufacturing ...

The US Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu ...

NodThera, a privately-held biotech working in chronic inflammatory diseases through selective modulation of the NLRP3 ...

Positive high-level results have been presented from the final overall survival (OS) analysis of the FLAURA2 Phase III trial.

Swiss pharma giant Roche today reported mixed results from late-stage trials for its experimental drug astegolimab, which is ...

South Korea’s biosimilar drug developer Samsung Bioepis today released its Third Quarter 2025 Market Report, marking the ...

The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...

The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment ...

Denmark-based allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and ...

Pittsburgh, USA-based Viatris, which was formed in 2020 through the merger of Mylan and Pfizer's, saw its shares fall 4.2% to ...